Loading
Current Research in Psychiatry
ISSN: 2768-3702
Digital companions, real casualties: A commentary on rising AI-related mental health crises
Reports of suicide linked to generative AI (GenAI) are increasing, yet regulatory responses remain fragmented and contested. Expanding on observations recently published by Head (2025), this commentary reviews documented AI-mediated suicide cases from 2022 to 2025 and evaluates current platform safety measures.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p1-5 | DOI: 10.46439/Psychiatry.6.043
The vexatious black box of psychiatry may be smaller because of this issue
Psychiatry is burdened by a much larger black box than several other medical practices. Some practitioners have chosen fields where mechanical interventions address a patient’s disability and so the black box is small. But psychiatry is one of those medical specialties whose practitioners confront perplexing unknowns.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p6-8 | DOI: 10.46439/Psychiatry.6.044
Improving pain psychology treatment initiation rates: an integrated evidence-informed framework
Psychological interventions represent a core component of contemporary interdisciplinary chronic pain treatment, yet treatment initiation following referral to pain psychology services remains consistently low. Empirical studies across behavioral health and pain medicine demonstrate that referral alone is insufficient to ensure patient engagement with psychological care. This gap between referral and treatment initiation represents a major implementation barrier limiting the impact of evidence-based psychological pain interventions.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p32-35 | DOI: 10.46439/Psychiatry.6.046
Stewardship of psychiatric healthcare utilization: the role of systems-based, community-based, and individually-based factors
As the demand for mental health care increases, acute care settings like emergency departments and inpatient psychiatric units have become overburdened. Intermediate levels of care and alternate treatment pathways are understudied and could efficiently utilize existing resources while also improving patient outcomes.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p9-31 | DOI: 10.46439/Psychiatry.6.045
Inflammation as a driver and consequence of addiction: translating Mendelian randomization findings into psychiatric practice and research
Substance use disorders (SUD) have long been diagnosed and monitored through subjective self-report, leaving a critical gap in objective biomarkers for subtyping, treatment response, and relapse prediction. Cao et al. provided pivotal genetic evidence for bidirectional causal relationships between addiction phenotypes and systemic inflammation using Mendelian Randomization (MR), a methodological breakthrough that opens a tangible path toward closing this gap.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p36-41 | DOI: 10.46439/Psychiatry.6.047
Why psychiatric outcomes aren’t improving
Despite significant improvements in somatic, pharmacologic, and psychotherapeutic treatments during the last century, clinical outcomes in psychiatry over the last few decades have stagnated . While many practitioners passively blame this on our inability to counter “treatment resistance,” and impatiently wait for new treatments that can, data shows us that the largest measure of the problem appears to be the quality of clinical practice we are employing.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p46-48 | DOI: 10.46439/Psychiatry.6.049
Enhancing primary cardiovascular prevention in patients with psychiatric disorders: a three-pronged approach
Patients with mental health disorders are at disproportionately greater risk of heart attack and stroke due to accelerated atherosclerotic cardiovascular disease. A three-tiered approach is considered herein to enhance access to primary cardiovascular prevention in clinical practice.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p49-51 | DOI: 10.46439/Psychiatry.6.050
Translating microbiome research into personalized schizophrenia care by implementing multi-omics and artificial intelligence
Schizophrenia is widely recognized as a multifactorial disorder involving interactions among the central nervous system, immune system, metabolism, and gut microbiome. Mardon et al. highlighted the potential importance of the gut-brain axis in schizophrenia. Building on this perspective, this commentary examines the next phase of schizophrenia research: translating biological discoveries into clinically meaningful applications.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p58-61 | DOI: 10.46439/Psychiatry.6.052
Depression diagnoses and treatment during pregnancy among women enrolled in Medicaid
Prenatal depression is common and may be associated with adverse prenatal and postpartum outcomes when untreated. However, treatment rates among pregnant women remain relatively low. As Medicaid is the largest public insurer during pregnancy in the United States, it is important to understand whether Medicaid beneficiaries receive appropriate depression treatment during pregnancy and the characteristics of women engaging in treatment.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p52-57 | DOI: 10.46439/Psychiatry.6.051
Closing the treatment gap: expanded access as the next step in psychiatry
A psychiatrist receives the following message from the family of a patient after her death: “A lot of people were surprised by her steep and rapid decline. My goal had always been to keep A home as long as I could. I am happy that I did keep her home, and the kids and I were with her when she passed at age 75! I want to thank you for all you did to access and help A in the clinical study. I believe that drug and study added a few years to her life so we could enjoy one another. I will miss her like crazy”.
Curr Res Psychiatry, 2026, Volume 6, Issue 1, p62-64 | DOI: 10.46439/Psychiatry.6.053